戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 pecially lung, ovarian and breast, can cause paraneoplastic cerebellar degeneration.
2 thophysiology were described 10 years ago in paraneoplastic cerebellar degeneration.
3                    Twenty-five patients with paraneoplastic cerebellar degeneration (44%) had high ti
4  was the cause of death of 65% HuAb positive paraneoplastic cerebellar degeneration and 10% HuAb nega
5                        A man in his 30s with paraneoplastic cerebellar degeneration and anti-Tr under
6     Here, we present a patient who developed paraneoplastic cerebellar degeneration and anti-Yo antib
7 e anti-Tr immune response is associated with paraneoplastic cerebellar degeneration and Hodgkin lymph
8 litis, 1 paraneoplastic encephalomyelitis, 1 paraneoplastic cerebellar degeneration, and 1 opsoclonus
9 rum and cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration associated with c
10 rocessed HLA-A2.1 restricted epitopes of the paraneoplastic cerebellar degeneration breast/ovarian ca
11 immunomodulation did not alter the course of paraneoplastic cerebellar degeneration, but improved Lam
12 at patients with the same tumour can develop paraneoplastic cerebellar degeneration by different immu
13 patients who differed from the HuAb negative paraneoplastic cerebellar degeneration cohort, HuAb posi
14 m of 57 patients with presenting symptoms of paraneoplastic cerebellar degeneration for the presence
15     A total of nine patients (16%) from both paraneoplastic cerebellar degeneration groups developed
16 /or serum samples from 5 other patients with paraneoplastic cerebellar degeneration, HL, and anti-Tr.
17     In patients with small-cell lung cancer, paraneoplastic cerebellar degeneration may occur with or
18  and immunological developments, focusing on paraneoplastic cerebellar degeneration, opsoclonus-myocl
19                  In other disorders, such as paraneoplastic cerebellar degeneration or paraneoplastic
20 erebellar degeneration and 10% HuAb negative paraneoplastic cerebellar degeneration patients (P < 0.0
21            In addition, 20% of HuAb negative paraneoplastic cerebellar degeneration patients without
22 0% of HuAb positive and 20% of HuAb negative paraneoplastic cerebellar degeneration patients, the tum
23 d in the peripheral blood of two HLA-A2.1(+) paraneoplastic cerebellar degeneration patients.
24                   For example, patients with paraneoplastic cerebellar degeneration (PCD) appear to s
25 among the better described autoantibodies in paraneoplastic cerebellar degeneration (PCD) combined wi
26                                   Except for paraneoplastic cerebellar degeneration (PCD) in HL and d
27                                              Paraneoplastic cerebellar degeneration (PCD) is a disord
28                                              Paraneoplastic cerebellar degeneration (PCD) is believed
29                                Patients with paraneoplastic cerebellar degeneration (PCD) offer the o
30                                Patients with paraneoplastic cerebellar degeneration (PCD) provide an
31 era from patients with Hodgkin's disease and paraneoplastic cerebellar degeneration resulted in the i
32                                 Furthermore, paraneoplastic cerebellar degeneration sometimes occurs
33 bodies associated with different cancers and paraneoplastic cerebellar degeneration suggests that sev
34                                Patients with paraneoplastic cerebellar degeneration who were HuAb pos

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。